This week's View covers articles about the rates of antiarrhythmic drug and catheter ablation use for the management of paroxysmal atrial fibrillation (AF) in terms of race/ethnicity and socioeconomic status, whether socioeconomic factors and sex differences play a role in changing trends in AF incidence and mortality, and the relationship between the renin-angiotensin-aldosterone system and ambulatory blood pressure (ABP) and ABP monitoring phenotypes among African Americans.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Arrhythmias and Clinical EP, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Implantable Devices, EP Basic Science, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Lipid Metabolism, Novel Agents, Acute Heart Failure, Hypertension

Keywords: EaglesEyeView, African Americans, Aldosterone, Anti-Arrhythmia Agents, Antihypertensive Agents, Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Blood Pressure Monitors, Catheter Ablation, Costs and Cost Analysis, Delivery of Health Care, Diuretics, Diuretics, Potassium Sparing, Ethnic Groups, Gross Domestic Product, Healthcare Disparities, Hypertension, Masked Hypertension, Income, Inpatients, Mineralocorticoid Receptor Antagonists, Minority Groups, Outpatients, Primary Prevention, Renin, Renin-Angiotensin System, Secondary Prevention, Sex Characteristics, Social Class, Social Determinants of Health, Socioeconomic Factors, White Coat Hypertension, Metabolic Syndrome, Dyslipidemias, Heart Failure

< Back to Listings